SCHEMBL22088747

SCHEMBL22088747

COC(=O)CCC1CC(=O)C2(C)CCC3c4ccc(Cl)cc4CCC3C12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STS P08842 2/20 0.48
▸ HSD17B1 P14061 6/20 0.46
▸ LMNA P02545 4/20 0.45
▸ CYP3A4 P08684 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ ESR1 P03372 2/20 0.45
▸ PGR P06401 2/20 0.45
▸ AR P10275 2/20 0.45
▸ AKR1B10 O60218 1/20 0.45
▸ SHBG P04278 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ SERPINA6 P08185 1/20 0.45
▸ CYP19A1 P11511 1/20 0.45
▸ AKR1B1 P15121 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ SLC6A4 P31645 1/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ SNCA P37840 1/20 0.45
▸ HTR2B P41595 1/20 0.45
▸ BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22089279 1.00 STS (0.48) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22236698 1.00 STS (0.48) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22088746 1.00 STS (0.48) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22236740 0.95 HSD17B1 (0.45) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22089431 0.93 STS (0.56) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22089405 0.93 STS (0.56) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22236702 0.93 STS (0.56) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22236691 0.90 STS (0.47) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22088765 0.90 STS (0.47) STSHSD17B1LMNACYP3A4MAPT
SCHEMBL22089406 0.90 STS (0.47) STSHSD17B1LMNACYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634975-B1 17-OXIMES OF 15.BETA.-[3-PROPANAMIDO]-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES FOR USE IN INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASES ORGANON R&D FINLAND LTD (FI) 2024-02-28 — — EP disclosed
WO-2020115371-A1 ESTRA-1,3,5(10)-TRIENE COMPOUNDS CONDENSED IN POSITION 16(17) WITH A PYRAZOLE RING AS INHIBITORS OF 17-HSD1 FORENDO PHARMA LTD (FI) 2020-06-11 — — WO disclosed
Send feedback